pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 19·1 min read
save

Protego Biopharma appoints Jae Kim as chief medical officer

Jun 19, 2026·read at STAT ↗Neutral

Protego Biopharma announced the addition of Jae Kim to its executive team as chief medical officer.

Kim comes to Protego after serving as chief medical officer at both Septerna and Design Therapeutics, bringing experience from those roles.

The appointment was highlighted in STAT+ as part of its regular feature on industry personnel moves.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Up and down the ladder: The latest comings and goings”

read at STAT ↗
459 words · retrieved Jun 19
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Design Therapeutics, Inc.ELI LILLY COLILLYNOVORISING
drugs
Obesity
topics
ApprovalObesityOncology

related stories

  • 6d agoSTAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and moreSTAT
  • Aug 19Amylyx’s redemption story, Summit’s survival woes, Definium’s anxiety win, moreBioSpace
  • Aug 12Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlightBioSpace
  • Aug 5Lilly confident in slow and steady Foundayo launch, as ex-US sales shineBioSpace
  • Jul 24Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myelomaBioPharma Dive